| HS Code | 317966 |
| Polymer Type | SEBS (styrene-ethylene-butylene-styrene) |
| Block Structure | linear triblock copolymer |
| Styrene Content | 30 wt% |
| Supply Form | powder |
| Appearance | white powder |
| Specific Gravity | 0.91 |
| Melt Flow Rate | 5 g/10 min (230 °C/2.16 kg) |
| Shore A Hardness | 65 Shore A |
| Tensile Strength | 30 MPa |
| Elongation At Break | 600% |
| 300 Percent Modulus | 6 MPa |
| Tear Strength | 30 kN/m |
| Bulk Density | 0.5 g/cm³ |
| Volatile Matter | <0.5 wt% |
| Ash Content | <0.2 wt% |
As an accredited Kraton Kraton™MD SEBS MD8705 HU factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Kraton™ MD SEBS MD8705 HU comes in 25 kg polyethylene-lined paper bags, palletized for industrial storage and handling. |
| Container Loading (20′ FCL) | Kraton Kraton™MD SEBS MD8705 HU loaded in 20′ FCL, palletized, shrink-wrapped, and secured for export shipment. |
| Shipping | Kraton MD SEBS MD8705 HU ships as a non-hazardous polymer in sealed containers and is not regulated for transport by DOT, IATA, or IMDG. Protect from moisture, heat, and sunlight; store in a cool, dry, well-ventilated area away from ignition sources. Avoid dust generation. |
| Storage | Store in a cool, dry, well-ventilated area away from direct sunlight, heat, ignition sources, and moisture. Keep containers tightly closed and clearly labeled. Avoid dust generation and accumulation, and keep away from strong oxidizers. Follow the manufacturer’s SDS and all local storage regulations. |
| Shelf Life | Kraton MD SEBS MD8705 HU has a shelf life of 24 months when stored unopened in original packaging under dry, ambient conditions. |
Compounding of low-durometer, gamma-sterilizable tubing compounds from Kraton™ MD SEBS MD8705 HU starts with a dry blend of 30–45 wt% MD8705 HU, 10–20 wt% paraffinic white oil, 0.05–0.20 wt% primary phenolic/phosphate antioxidant, and a polypropylene random copolymer balance. The low bound styrene content of 13 wt% creates a processing window lower than that of standard 30 wt% styrene SEBS grades; disperse-phase styrene domains are smaller, and elastic memory in the melt is lower, but stock temperatures above 220°C at the die plate can initiate localised gel formation unless the screw profile places the first oil injection after a reverse kneading block and repeats a left-handed element at barrel 8 of 12. Pre-drying at 70°C for 2 hours is required when pellet moisture exceeds 0.05 wt% before single-screw tube extrusion, because trace moisture at these temperatures is sufficient to generate surface roughness on the inner lumen.
Compounding is run on a co-rotating twin-screw extruder with L/D 40:1 to 48:1, vacuum venting at -0.08 MPa, melt temperature 200–215°C at the die, and underwater pelletizing at 20–40°C. The compound is then processed on a barrier-screw single-screw extruder with a tube die at 190–210°C; screw speeds above 60 min⁻¹ can generate shear heating beyond the degradation threshold when barrel zone 3 exceeds 210°C. Tubing is gamma-irradiated at 25–50 kGy or processed by ethylene oxide. Compliance verification includes ISO 10993-5:2009 and ISO 10993-10:2010 extracts, USP <88> Class VI systemic injection, and FDA 21 CFR 177.1810 for food-contact constructions.
| Compliance boundary | Standard designation | Test condition | Acceptance limit |
| Cytotoxicity | ISO 10993-5:2009 | MEM elution, 37°C, 24 h | ≤ Grade 2 |
| Intracutaneous reactivity | ISO 10993-10:2010 | 0.9% NaCl and sesame oil extracts | No erythema/edema ≥ 1.0 |
| Systemic toxicity | USP <88> Class VI | NaCl, alcohol, PEG 400, sesame oil | Pass |
| Elastomeric closure physicochemical | USP <381> | Water vapour, UV, pH, heavy metals | Ph. Eur. limits |
Finished product types include peristaltic pump tubing, enteral feeding lines, cardiotomy suction tubing, and medical fluid transfer lines.
In blown film, the typical addition ratio is 20–35 wt% MD8705 HU, balanced by a polypropylene random copolymer carrier, 0.05–0.15 wt% clarifier/nucleator, and 0.10–0.20 wt% slip/antiblock masterbatch. The central process conflict is between domain dispersion and film clarity: raising the melt temperature toward 230°C lowers SEBS domain size and improves low-temperature puncture resistance, but it also suppresses PP beta-crystal growth and can raise haze values measured by ASTM D1003-21 from 2–5% toward 10–15% in thick-gauge sections. Conversely, when melt temperature falls below 200°C, insufficient plasticating of the high-molecular-weight SEBS phase produces visible gel streaks that cannot be removed by downstream orientation. A stable production window on a single-screw blown-film line requires L/D 30:1, a Maddock mixing head in the metering section, die gap 0.8–1.2 mm, blow-up ratio 2.0:1–2.5:1, frost line height 300–400 mm, and melt pressure at the die not exceeding 300 bar.
Compliance for pharmaceutical overwrap is anchored to FDA 21 CFR 177.1810, EU 10/2011, USP <661.1>, and ISO 10993-5:2009 for indirect contact; mechanical acceptance tests follow ISO 527-3:2018 for tensile properties and ISO 7765-1:2010 for puncture impact. Finished product types include IV fluid bag overwrap, pharmaceutical pouch film, cleanroom packaging, and sterile barrier film for medical device trays.
Pressure-sensitive adhesive formulations for extended-wear skin-contact applications use MD8705 HU at 15–25 wt% of the total matrix, fully hydrogenated hydrocarbon tackifier at 45–55 wt%, paraffinic process oil at 15–25 wt%, and 0.5–1.0 wt% stabilizer package. Mixing in a vertical high-shear or sigma-blade mixer is maintained at 165–180°C with nitrogen blanket; total hold time above 120 min is not recommended because tackifier dimerization increases low-shear viscosity at 1 rad/s and narrows the slot-die coating window. The adhesive is applied through a slot die at 130–150°C onto silicone release liner at line speeds 50–200 m/min, then laminated to nonwoven or polyurethane film under 3–6 N/mm nip pressure. Addition of MD8705 HU above 25 wt% produces elastic recovery but reduces tack loop values; below 15 wt%, the formulation loses skin-immersion cohesion after 24 hours of wear. Antioxidant selection is limited to phenolic/phosphate systems; amine-based antioxidants are excluded because they elevate extractable levels and cause yellowing after gamma exposure.
Compliance boundaries include ISO 10993-5:2009 and ISO 10993-10:2010 for skin contact, FDA 21 CFR 175.105(a) for adhesive components, EU 10/2011 where the construction contacts food, REACH SVHC screening, and RoHS recast. Finished products include wearable diagnostic patch adhesives, ostomy baseplate systems, hospital securement dressings, and transdermal over-tapes.
On two-shot injection moulding machines, overmoulding compounds based on MD8705 HU are usually formulated at 20–40 wt% in a polypropylene random copolymer carrier, with 10–20 wt% paraffinic oil if the target hardness is below 60 Shore A per ASTM D2240-15. The first-shot PP insert surface temperature is held at 30–50°C; the second-shot melt temperature is 190–220°C, injection velocity 40–80 mm/s, holding pressure 30–50 MPa, and screw recovery pressure not exceeding 5 MPa to avoid excessive shear heating. Gate blush is observed in high-cavitation tools when injection velocity exceeds 80 mm/s and gate melt temperature exceeds 230°C due to shear conversion. Adhesion drops below the required 2 N/mm peel threshold when the first-shot surface temperature is below 20°C, when silicone-containing mould release is present, or when tool venting is less than 0.02 mm along the flow-front split line. Interdiffusion between the SEBS domain and the PP-rich first-shot skin is sensitive to external release oil; addition above 5 wt% reduces interfacial tensile pull-off force and should be avoided.
Compliance standards for medical and food-contact devices include USP <88> Class VI, FDA 21 CFR 177.1810, ISO 10993-5:2009, and RoHS recast; mechanical methods include ISO 527-2:2012 tensile, ISO 178:2019 flexural, and ASTM D2240-15 hardness. Finished product types include inhaler housings, surgical tool handles, diagnostic instrument grips, and pill dispenser overmoulds.
Vial stopper, syringe tip cap, and dropper bulb compounds use MD8705 HU at 30–50 wt%, 10–20 wt% PP random copolymer, 20–35 wt% high-purity naphthenic or paraffinic oil, and 0–5 wt% silica anti-block. The saturated ethylene-butylene midblock of MD8705 HU is the critical formulation boundary: gamma irradiation at 25–50 kGy does not generate the oxidative embrittlement and crosslink-density shifts typical of unsaturated elastomers, but residual aromatic extracts from the oil phase still elevate leachable profiles. The oil phase is therefore specified with aromatic content below 1 wt%, and the finished closure compound is subjected to extractable mass testing under USP <381>, USP <661.1>, and ISO 10993-5:2009. Injection compression moulding in multi-cavity cold-runner tools runs at melt 190–210°C, injection pressure 50–80 MPa, mould temperature 25–40°C, and cycle times 15–30 s. Fragmentation and penetrability tests after autoclave at 121°C for 30 min are run before release.
Finished product types include pre-fillable syringe tip caps, vial stoppers, dropper bulbs, and needle shields. Peroxide crosslinking is not applicable because the saturated midblock has no practical vulcanisation kinetics; this limitation defines the upper continuous load-bearing service temperature of the construction at approximately 70°C.
Where elastic film is laminated to spunbond nonwoven for medical and hygiene covers, MD8705 HU is extruded at 30–50 wt% of the film blend, with 20–40 wt% polypropylene random copolymer, 5–15 wt% hydrogenated hydrocarbon tackifier, and 10–20 wt% paraffinic oil. Cast-film extrusion is run on a single-screw unit with L/D 30:1, melt temperature 190–210°C, slot die gap 0.3–0.5 mm, and chill roll temperature 15–25°C. Film basis weight is 25–60 g/m², and machine-direction elongation is 400–600% when measured by ISO 527-3:2018. The molten film is married to spunbond nonwoven at nip pressure 3–5 N/mm; draw resonance appears when line speed exceeds 150 m/min, and die-lip shear stress above 0.15 MPa induces melt fracture. Stretching after lamination is performed in-line at 100–300% to activate elasticity.
Compliance boundaries include ISO 10993-5:2009 and ISO 10993-10:2010 for skin contact, FDA 21 CFR 177.1810, and EU 10/2011 where the laminating construction is used in food-contact applications. Finished product types include medical gown cuffs, surgical drape elastic bands, hygiene waistbands, and wound dressing backing films.
Competitive Kraton Kraton™MD SEBS MD8705 HU prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Among hydrogenated styrenic block copolymers used in medical and regulated elastomer applications, Kraton™ MD8705 HU is a linear styrene-ethylene/1-butene-styrene triblock copolymer supplied as neat pellets. The grade is not a finished compound; it is a base SEBS polymer with controlled molecular architecture, low gel content, and medical-grade lot release. Bound styrene, diblock content, melt viscosity, and extractables are controlled to reduce batch-to-batch variation in downstream tubing, film, gaskets, and injection-molded components. The saturated ethylene-1-butene midblock replaces the polydiene unsaturation of SBS and SIS, which alters oxidation resistance, ultraviolet exposure response, sterilization compatibility, and adhesion-cohesion balance. The designation MD8705 HU identifies a hydrogenated medical variant within the Kraton styrenic block copolymer portfolio; the HU suffix is a manufacturer-specific grade indicator rather than a specification limit.
Lot-release testing for the neat polymer is reported under ISO and ASTM methods. The density is typically 0.90 g/cm³ when measured by ISO 1183-1:2019. Shore A hardness is 42–48 after 10 s by ISO 48-4:2018. Tensile properties are determined by ISO 37:2017 on Type 2 dumbbells conditioned at 23 ± 2 °C; representative tensile strength at break is 4.0–6.0 MPa, elongation at break is 600–850%, and 300% modulus is 1.0–1.5 MPa. Melt mass-flow rate by ISO 1133-1:2022 at 230 °C under 5 kg is 0.8–2.5 g/10 min. Bound styrene is 12–14 wt% by an internal spectroscopic method; diblock content is controlled below <1 wt%. These are representative ranges, not specification limits. The certificate of analysis establishes the limit for each lot, and design calculations should not rely on single-point values. The low Shore A range and high elongation make the polymer suitable for soft-touch overmolded grips, kink-resistant tubing, and diaphragms. However, tensile set and stress relaxation are not zero; sustained compressive strain above 20% at 40 °C results in measurable stress relaxation. Designers using ISO 3384 stress-relaxation testing should evaluate the specific compound rather than the neat polymer because oil extension and polypropylene addition shift both hardness and relaxation behavior.
| Property | Test method | Representative range |
|---|---|---|
| Density | ISO 1183-1:2019 | 0.89–0.91 g/cm³ |
| Bound styrene | Internal FTIR | 12–14 wt% |
| Diblock content | Internal GPC | <1 wt% |
| Shore A hardness | ISO 48-4:2018 | 42–48 after 10 s |
| Tensile strength at break | ISO 37:2017 | 4.0–6.0 MPa |
| Elongation at break | ISO 37:2017 | 600–850% |
| 300% modulus | ISO 37:2017 | 1.0–1.5 MPa |
| Melt mass-flow rate | ISO 1133-1:2022 | 0.8–2.5 g/10 min at 230 °C/5 kg |
Processing of MD8705 HU begins with moisture control. Pellets stored at relative humidity above 60% are dried at 60–70 °C for 2–4 h to bring moisture below 0.05%. On corotating twin-screw extruders with L/D ratios of 24:1 to 30:1, a flat barrel-temperature profile of 180–220 °C is applied. At screw speeds above 300 rpm, viscous dissipation can increase melt temperature by 5–15 °C above the set point; barrel cooling on the feed throat and closed-loop melt-temperature control are used to avoid exceeding 250 °C. Dead spots at the screen pack, pressure transducer ports, and static mixers are potential gel-initiating zones because the saturated midblock undergoes auto-oxidation when residence time at high temperature combines with oxygen ingress. Purging with a polyolefin after shutdown and minimizing hold time above 240 °C is therefore standard. For single-screw profile extrusion, a screw with a compression ratio of 2.5:1 to 3.5:1 and melt temperatures of 200–230 °C are appropriate for thin-wall tubing lines. Injection molding onto polypropylene cores uses melt temperatures of 200–230 °C, mold temperatures of 25–50 °C, and fill speeds sufficient to limit weld-line weakness. Weld-line tensile retention is lower than bulk tensile values because the polymer is thermoplastic and does not re-entangle fully across a cooled weld interface; published data for this specific configuration is limited unless a dedicated weld-line specimen program is run under ISO 527-2 or ISO 37 adapted to injection-molded plaques.
Because the ethylene-1-butene midblock is saturated, ionizing radiation tends to induce chain scission in the polystyrene domains and at chain ends rather than forming allylic radicals. The material is therefore specified for devices requiring gamma doses up to 50 kGy or electron-beam sterilization up to 50 kGy; however, oxidative after-reactions in oxygen-permeable thin sections remain a design variable. Tensile retention after gamma exposure is influenced by wall thickness, antioxidant package, and post-irradiation aging temperature. Published data for this specific formulation is limited when the exact compounding recipe is not fixed; final radiation master plans should include tensile retention, color shift, and crosslink density under ISO 11137-1. Unlike plasticized vinyl compounds, MD8705 HU does not rely on low-molecular-weight ortho-phthalate plasticizers, so plasticizer migration into drug formulations or extraction media is not introduced. Additives such as antioxidants and colorants may still extract; extraction studies should follow ISO 10993-12:2021. Repeated autoclave cycles at 121 °C and 134 °C are possible for short durations, but the polymer softens near the polystyrene glass transition at 95–105 °C. Sustained mechanical load at autoclave temperatures should not be applied unless dimensional stability and creep behavior are validated on the finished component.
Compared with styrene-butadiene-styrene block copolymers, the saturated midblock of MD8705 HU has a higher onset temperature for thermo-oxidative degradation and is resistant to ozone cracking, but requires hydrogenated tackifiers and oils in adhesive or sealant formulations. Compared with styrene-isoprene-styrene block copolymers, the polymer is stiffer at equivalent molecular weight and has lower tack; its melt processing window is narrower because higher temperatures are needed to reduce viscosity while upper limits remain below 260 °C. Compared with ethylene-propylene diene monomer rubber, MD8705 HU is reprocessable, oil-free, and has higher melt strength for profile extrusion, but compression set and hot-oil swelling are generally less favorable. Against thermoplastic polyurethane elastomers of similar Shore A hardness, MD8705 HU has lower density, better hydrolytic resistance, and lower hardness without plasticizer; tensile strength, abrasion resistance, and tear strength are lower. Against reactor thermoplastic polyolefins, the SEBS gives more consistent softness in the 40–50 Shore A range, higher elastic recovery, and better low-temperature flexibility, but flexural modulus and upper continuous-use temperature are lower. These differences make MD8705 HU a candidate for soft medical tubing, protective films, overmolding, and drug-contact seals where the combination of low hardness, plasticizer-free construction, and saturated backbone stability is functionally required.
For medical-device programs, the polymer is supplied with documentation that may include a device master file, ISO 10993-5 cytotoxicity data on the neat polymer, and USP <87> and USP <88> biological reactivity testing. These data support, but do not replace, finished-device biocompatibility evaluation under ISO 10993-1:2018. The polymer is not intentionally formulated with phthalates, bisphenol A, latex proteins, or polyvinyl chloride; absence of intentional addition is not equivalent to zero extractables. Extractables and leachables testing under ISO 10993-12:2021 or ISO 10993-18:2020 is required for the final compounded and sterilized component. For food-contact applications, FDA 21 CFR 177.1810 may apply to styrene block copolymers, but medical-grade use requires verification against the final formulation, sterilization method, and target patient-contact duration.
| Regulatory or technical endpoint | Standard or method | Application boundary |
|---|---|---|
| Cytotoxicity | ISO 10993-5 | Neat polymer data; final compound verification required |
| In vitro biological reactivity | USP <87> | Neat polymer documentation |
| Implantation | USP <88> | Class VI data package where manufacturer provides |
| Extractables sample preparation | ISO 10993-12:2021 | Finished device after sterilization |
| Radiation sterilization | ISO 11137-1 | Dose validation on packaged device |
| Food-contact styrenic block copolymers | FDA 21 CFR 177.1810 | Indirect or repeated-contact use where applicable |